BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20497539)

  • 1. Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up.
    Dvorakova M; Dhir R; Bastacky SI; Cieply KM; Acquafondata MB; Sherer CR; Mercuri TL; Parwani AV
    Diagn Pathol; 2010 May; 5():32. PubMed ID: 20497539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
    Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
    Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
    Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
    Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma.
    Brunelli M; Eble JN; Zhang S; Martignoni G; Delahunt B; Cheng L
    Mod Pathol; 2005 Feb; 18(2):161-9. PubMed ID: 15467713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FISH analysis in chromophobe renal-cell carcinoma.
    Iqbal MA; Akhtar M; Ulmer C; Al-Dayel F; Paterson MC
    Diagn Cytopathol; 2000 Jan; 22(1):3-6. PubMed ID: 10613963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
    Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
    Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interphase cytogenetic analysis with centromeric probes for chromosomes 1, 2, 6, 10, and 17 in 11 tumors from a patient with bilateral renal oncocytosis.
    Cossu-Rocca P; Eble JN; Zhang S; Bonsib SM; Martignoni G; Brunelli M; Cheng L
    Mod Pathol; 2008 Apr; 21(4):498-504. PubMed ID: 18246052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma.
    Brunelli M; Segala D; Delahunt B; Parolini C; Bersani S; Cheng L; Eble JN; Chilosi M; Gobbo S; Martignoni G
    Anticancer Res; 2011 Oct; 31(10):3137-42. PubMed ID: 21965719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
    Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
    Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
    [No Abstract]   [Full Text] [Related]  

  • 11. Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.
    Ruiz-Cordero R; Rao P; Li L; Qi Y; Atherton D; Peng B; Singh RR; Kim TB; Kawakami F; Routbort MJ; Alouch N; Chow CB; Tang X; Lu W; Brimo F; Matin SF; Wood CG; Tannir NM; Wistuba II; Chen K; Wang J; Medeiros LJ; Karam JA; Tamboli P; Sircar K
    Mod Pathol; 2019 Nov; 32(11):1698-1707. PubMed ID: 31231128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A collision tumor of papillary renal cell carcinoma and oncocytoma: case report and literature review.
    Goyal R; Parwani AV; Gellert L; Hameed O; Giannico GA
    Am J Clin Pathol; 2015 Nov; 144(5):811-6. PubMed ID: 26486747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms.
    Zhu B; Rohan SM; Lin X
    Cancer Cytopathol; 2020 Dec; 128(12):962-970. PubMed ID: 32697415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
    An J; Park CK; Kim M; Joo JW; Cho NH
    Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
    Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
    Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion (8;11) in a renal oncocytoma with multifocal transformation to chromophobe renal cell carcinoma.
    Salido M; Lloreta J; Melero C; García M; Placer J; Espinet B; Villa O; Bielsa O; Gelabert-Mas A; Serrano S; Solé F
    Cancer Genet Cytogenet; 2005 Dec; 163(2):160-3. PubMed ID: 16337860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas.
    Poté N; Vieillefond A; Couturier J; Arrufat S; Metzger I; Delongchamps NB; Camparo P; Mège-Lechevallier F; Molinié V; Sibony M
    Virchows Arch; 2013 Jun; 462(6):633-8. PubMed ID: 23708994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
    Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC
    Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
    Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
    Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma.
    Flack CK; Calaway AC; Miller BL; Picken MM; Gondim DD; Idrees MT; Abel EJ; Gupta GN; Boris RS
    Urol Oncol; 2019 Nov; 37(11):811.e17-811.e21. PubMed ID: 31451335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.